- Organizations: Eclipse Life Sciences
Pipeline
Eclipse reports positive phase 2 topline data on DME steroid implant
EC-104 demonstrated durability, consistent anatomical response, and a strong safety profile; company eyes pivotal program in 2027.Pipeline